Clinical Trial Update: Study of Lactobacillus in Adjuvant Treatment of RVVC [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating Lactobacillus as adjuvant therapy for recurrent vulvovaginal candidiasis has completed. The study was sponsored by Peking Un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvovaginal Candidiasis

Drugs mentioned

• Lactobacillus probiotic (Lactobacillus)

Snippet

Sponsor: Peking University Shenzhen Hospital | Conditions: Recurrent Vulvovaginal Candidiasis | Phase 4 | Status: COMPLETED